Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — Financial Flexibility Index
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Financial Flexibility Index of -0.11x as of September 2025. Free cash flow of CN¥-4.77 Million (operating CF CN¥-8.22 Million minus capex CN¥3.45 Million) represents 0% of total liabilities (CN¥45.34 Million). Check how aggressively does Qinghai Spring Medicinal Resources Techn reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Qinghai Spring Medicinal Resources Technology Co Ltd Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Qinghai Spring Medicinal Resources Technology Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see Qinghai Spring Medicinal Resources Techn cash conversion from operations.
Annual Financial Flexibility Index for Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)
Year-by-year free cash flow to debt coverage for Qinghai Spring Medicinal Resources Technology Co Ltd. Explore 600381 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.44x | CN¥-19.86 Million | CN¥-26.41 Million | CN¥44.87 Million | ▼ -166.0% |
| 2024 | 0.67x | CN¥85.90 Million | CN¥80.97 Million | CN¥128.02 Million | ▲ +64.8% |
| 2023 | 0.41x | CN¥37.45 Million | CN¥23.92 Million | CN¥91.99 Million | ▲ +134.5% |
| 2022 | -1.18x | CN¥-31.00 Million | CN¥-31.82 Million | CN¥26.30 Million | ▼ -156.3% |
| 2021 | 2.09x | CN¥57.86 Million | CN¥-63.93 Million | CN¥27.64 Million | ▲ +139.8% |
| 2020 | 0.87x | CN¥119.68 Million | CN¥-77.95 Million | CN¥137.08 Million | ▲ +107.6% |
| 2019 | -11.47x | CN¥-231.01 Million | CN¥-236.30 Million | CN¥20.14 Million | ▼ -330.3% |
| 2018 | -2.67x | CN¥-140.46 Million | CN¥-183.97 Million | CN¥52.68 Million | ▼ -360.0% |
| 2017 | 1.03x | CN¥116.47 Million | CN¥95.74 Million | CN¥113.56 Million | ▼ -42.7% |
| 2016 | 1.79x | CN¥370.41 Million | CN¥344.99 Million | CN¥206.95 Million | ▼ -25.1% |
| 2015 | 2.39x | CN¥847.42 Million | CN¥832.17 Million | CN¥354.60 Million | ▲ +7496.8% |
| 2014 | 0.03x | CN¥35.45 Million | CN¥-89.64 Million | CN¥1.13 Billion | ▼ -6.4% |
| 2013 | 0.03x | CN¥48.38 Million | CN¥-28.09 Million | CN¥1.44 Billion | ▲ +112.3% |
| 2012 | -0.27x | CN¥-520.85 Million | CN¥-701.18 Million | CN¥1.90 Billion | ▼ -195.7% |
| 2011 | 0.29x | CN¥463.38 Million | CN¥249.98 Million | CN¥1.62 Billion | ▼ -39.8% |
| 2010 | 0.48x | CN¥446.18 Million | CN¥71.47 Million | CN¥938.58 Million | ▲ +259.0% |
| 2009 | 0.13x | CN¥69.60 Million | CN¥39.16 Million | CN¥525.60 Million | ▲ +125.6% |
| 2008 | 0.06x | CN¥34.57 Million | CN¥20.83 Million | CN¥589.02 Million | ▲ +492.3% |
| 2007 | 0.01x | CN¥7.01 Million | CN¥7.00 Million | CN¥707.61 Million | ▼ -60.3% |
| 2006 | 0.02x | CN¥21.57 Million | CN¥21.57 Million | CN¥863.38 Million | ▼ -84.0% |
| 2005 | 0.16x | CN¥162.95 Million | CN¥162.12 Million | CN¥1.05 Billion | ▲ +308.7% |
| 2004 | 0.04x | CN¥46.68 Million | CN¥33.83 Million | CN¥1.22 Billion | ▼ -71.8% |
| 2003 | 0.14x | CN¥106.92 Million | CN¥1.43 Million | CN¥789.85 Million | ▼ -35.0% |
| 2002 | 0.21x | CN¥86.57 Million | CN¥15.54 Million | CN¥415.90 Million | ▲ +24.4% |
| 2001 | 0.17x | CN¥44.34 Million | CN¥-10.64 Million | CN¥264.94 Million | ▼ -32.6% |
| 2000 | 0.25x | CN¥46.65 Million | CN¥4.52 Million | CN¥187.91 Million | ▼ -74.0% |
| 1999 | 0.95x | CN¥122.21 Million | CN¥70.28 Million | CN¥128.04 Million | — |